<DOC>
	<DOC>NCT01153958</DOC>
	<brief_summary>This is a prospective, randomized, controlled and multi-center trial to assess the use of colposeptine in female subjects with bacterial vaginosis. A total of 480 subjects were planned to be enrolled in various centers in China.</brief_summary>
	<brief_title>Colposeptine for the Treatment of Bacterial Vaginosis</brief_title>
	<detailed_description />
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis, Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Chlorquinaldol</mesh_term>
	<criteria>Female subjects in reproductive age and older than 18 year Subjects with normal sexual activity Subjects with symptoms such as vulvavaginal irritation or abnormal vaginal discharge Subjects with Nugent Score greater than or equal to 7 Subjects who are willing to use contraception Subjects who are willing to refrain from the use of other vaginal products throughout the study Subjects who sign informed consent form and agree to followup on time Subjects without sexual activity Pregnant or lactating female subjects Subjects with a history of recurrent bacterial vaginosis Subjects diagnosed with trichomonas vaginitis，vulvovaginal candidiasis，chlamydia or gonococcus infection. Subjects who are unwilling to refrain from the ingestion of any alcoholic beverages during the 7 day course of oral metronidazole therapy Subjects who are under treatment by lithium, phenobarbitone, coumadine anticoagulant, cyclosporine or disulfiram by the time of inclusion (interactions with other products and metronidazole) Subjects who are undergoing systemic or topical treatment with antibiotics, steroids, immunosuppressive, cytostatic or antimetabolic agents by the time of inclusion Female subjects with a history of peripheral neuropathy Female subjects who have participated in another clinical trial or have taken an experimental drug within the past 30 days Subjects who are unable to give written informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Vaginosis, Bacterial</keyword>
	<keyword>Colposeptine</keyword>
	<keyword>Metronidazole</keyword>
</DOC>